Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On March 6, 2023, the board of directors (the “Board of Directors”) of Community
Healthcare Trust Incorporated (the “Company”), appointed David H. Dupuy, who has
served as the Company’s Interim Chief Executive Officer since February 10, 2023,
to be the Company’s Chief Executive Officer on a permanent basis. Mr. Dupuy was
also appointed to the Board of Directors of the Company, effective as of
March 6, 2023, to fill the vacancy created by the death of Timothy G. Wallace.
Mr. Dupuy will continue to serve as the Company’s Chief Financial Officer until
a successor is chosen for that position.
Mr. Dupuy, 54, has served as the Company’s Interim Chief Executive Officer since
February 10, 2023 and Executive Vice President and Chief Financial Officer since
May 2019. From 2008 to 2019, Mr. Dupuy served as a Managing Director, Healthcare
Investment Banking Group at SunTrust Robinson Humphrey (now “Truist Securities”
or “Truist”). From 2004 to 2008, Mr. Dupuy served as a Senior Vice President of
the Healthcare Group at Bank of America. From 2000 to 2004, Mr. Dupuy served as
a Vice President and Regional Director for KDA Holdings with responsibility for
consulting, financing, and development of outpatient medical facilities.
Previously, Mr. Dupuy served as Chief Financial Officer and Founding Partner of
LIFESIGNS Holdings, Inc., a provider of diagnostic healthcare services, from
1997 to 2000. Mr. Dupuy began his career in 1991 with Bank of America. Mr. Dupuy
holds a Bachelor of Arts in Business Administration from Furman University and a
Master of Business Administration from the Owen School at Vanderbilt University.
There are no arrangements or understandings between Mr. Dupuy and any other
persons pursuant to which he was appointed Chief Executive Officer. Further,
there are no arrangements or understandings between Mr. Dupuy and any other
persons pursuant to which he was appointed to the Board of Directors. In
addition, there are no family relationships between Mr. Dupuy and any director
or executive officer of the Company. Mr. Dupuy has not been party to any
reportable transactions with the Company pursuant to Item 404(a) of Regulation
S-K.
Item 7.01 Regulation FD Disclosure.
On March 7, 2023, the Company issued a press release announcing Mr. Dupuy’s
appointment as Chief Executive Officer and to the Board of Directors. A copy of
the Company’s press release is furnished hereto as Exhibit 99.1.
This information furnished pursuant to this Item 7.01, including Exhibit 99.1,
shall not be deemed “filed” for purposes of Section 18 of the Exchange Act, or
otherwise subject to the liabilities under that section and shall not be deemed
to be incorporated by reference into any filing under the Securities Act or the
Exchange Act.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits Exhibit No. Description 99.1 Press release, dated March 7, 2023 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
© Edgar Online, source Glimpses
postbrexitcompliance.com 